BFC Planning’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
SL
BFC Planning's DYN Position: Q3 2026 in Review
BFC Planning increased its Dyne Therapeutics (DYN) stake by 116% in Q3 2026, buying an estimated $2.53K and bringing the position to 205 shares worth $3.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2846.
BFC Planning first reported a position in DYN in Q1 2026 and has held it in 3 quarters since. 179 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- BFC Planning held 205 shares of Dyne Therapeutics worth $3.3K as of Q3 2026.
- BFC Planning bought 110 Dyne Therapeutics shares in Q3 2026, an estimated $2.53K.
- Dyne Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2846 holding.
- BFC Planning first reported a position in Dyne Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 179 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.